Lysergic acid diethylamide-assisted therapy for anxiety with or without life-threatening illness: phase II trial
Zusammenfassung
Randomized, double-blind, placebo-controlled phase II crossover trial of LSD-assisted therapy in patients with anxiety, with and without life-threatening illness. Two dosing sessions were paired with structured psychotherapy and integration. Anxiety and depression ratings improved through follow-up with generally mild, transient adverse effects, supporting further controlled trials.
Schlüsselwörter
LSDanxietyphase IIrandomized trialpsychotherapycrossoverdepressionsafety
Klinische Forschung